Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 Jul 20;2005(3):CD003937.
doi: 10.1002/14651858.CD003937.pub2.

Herbal medicines for treating HIV infection and AIDS

Affiliations
Review

Herbal medicines for treating HIV infection and AIDS

J P Liu et al. Cochrane Database Syst Rev. .

Abstract

Background: HIV-infected people and AIDS patients often seek complementary therapies including herbal medicines due to reasons such as unsatisfactory effects, high cost, non-availability, or adverse effects of conventional medicines.

Objectives: To assess beneficial effects and risks of herbal medicines in patients with HIV infection and AIDS.

Search strategy: Electronic searches included the Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, LILACS, Science Citation Index, the Chinese Biomedical Database, TCMLARS; plus CISCOM, AMED, and NAPRALERT; combined with manual searches. The search ended in December 2004.

Selection criteria: Randomized clinical trials on herbal medicines compared with no intervention, placebo, or antiretroviral drugs in patients with HIV infection, HIV-related disease, or AIDS. The outcomes included mortality, HIV disease progression, new AIDS-defining event, CD4 cell counts, viral load, psychological status, quality of life, and adverse effects.

Data collection and analysis: Two authors extracted data independently and assessed the methodological quality of trials according to randomization, allocation concealment, double blinding, and drop-out.

Main results: Nine randomized placebo-controlled trials involving 499 individuals with HIV infection and AIDS met the inclusion criteria. Methodological quality of trials was assessed as adequate in five full publications and unclear in other trials. Eight different herbal medicines were tested.A compound of Chinese herbs (IGM-1) showed significantly better effect than placebo in improvement of health-related quality of life in 30 symptomatic HIV-infected patients (WMD 0.66, 95% CI 0.05 to 1.27). IGM-1 appeared not to affect overall health perception, symptom severity, CD4 count, anxiety or depression (Burack 1996a). An herbal formulation of 35 Chinese herbs did not affect CD4 cell counts, viral load, AIDS events, symptoms, psychosocial measure, or quality of life (Weber 1999). There was no statistical difference between SPV30 and placebo in new AIDS-defining events, CD4 cell counts, or viral load (Durant 1998) although an earlier pilot trial showed positive effect of SPV30 on CD4 cell count (Durant 1997). Combined treatment of Chinese herbal compound SH and antiretroviral agents showed increased antiviral benefit compared with antiretrovirals alone (Sangkitporn 2004). SP-303 appeared to reduce stool weight (p = 0.008) and abnormal stool frequency (p = 0.04) in 51 patients with AIDS and diarrhoea (Holodniy 1999). Qiankunning appeared not to affect HIV-1 RNA levels (Shi 2003), Curcumin ineffective in reducing viral load or improving CD4 cell counts (Hellinger 1996), and Capsaicin ineffective in relieving pain associated with HIV-related peripheral neuropathy (Paice 2000). The occurrence of adverse effects was higher in the 35 Chinese herbs preparation (19/24) than in placebo (11/29) (79% versus 38%, p = 0.003) (Weber 1999). Qiankunning was associated with stomach discomfort and diarrhoea (Shi 2003).

Authors' conclusions: There is insufficient evidence to support the use of herbal medicines in HIV-infected individuals and AIDS patients. Potential beneficial effects need to be confirmed in large, rigorous trials.

PubMed Disclaimer

Conflict of interest statement

We certify that we have no affiliations with or involvement in any organization or entity that has direct or indirect financial interest in the subject matter of the review.

Figures

1.1
1.1. Analysis
Comparison 1 Herbal medicines versus placebo, Outcome 1 Occurrence of AIDS‐related events.
1.2
1.2. Analysis
Comparison 1 Herbal medicines versus placebo, Outcome 2 CD4 cell count less than 20 millions per litre.
1.3
1.3. Analysis
Comparison 1 Herbal medicines versus placebo, Outcome 3 Overall health perception (no. improved).
1.4
1.4. Analysis
Comparison 1 Herbal medicines versus placebo, Outcome 4 CD4 cell count ( X 10 6/L).
1.5
1.5. Analysis
Comparison 1 Herbal medicines versus placebo, Outcome 5 Viral load (log unit or copies/ml).
1.6
1.6. Analysis
Comparison 1 Herbal medicines versus placebo, Outcome 6 Overall life satisfaction.

Update of

  • doi: 10.1002/14651858.CD003937

Similar articles

Cited by

References

References to studies included in this review

Burack 1996 {published data only}
    1. Burack JH, Cohen MR, Hahn JA, Abrams DI. Pilot randomized controlled trial of Chinese herbal treatment for HIV‐associated symptoms. Journal of Acquired Immune Deficiency Syndrome Human Retrovirology 1996;12(4):386‐93. - PubMed
Durant 1997 {published data only}
    1. Durant J, Rebouillat A, Dellamonica P, Condom R, Patino N, Pugliese P, et al. Efficacy of SPV on asymptomatic HIV‐positive patients: a randomised, double‐blind, placebo controlled trial. IV Congress of the Mediterranean Society of Infectious and Parasitic Diseases. Paris, 1997:P30/59.
Durant 1998 {published data only}
    1. Durant J, Chantre PH, Gonzalez G, Vandermander J, Halfon PH, Rousse B. Efficacy and safety of Buxus semperirens L. preparations (SPV 30) in HIV‐infected asymptomatic patients: a multicentre, randomized, double‐blind, placebo‐controlled trial. Phytomedicine 1998;5(1):1‐10. - PubMed
Hellinger 1996 {published data only}
    1. Hellinger JA. Phase I/II randomized, open‐label study of oral curcumin safety, and antiviral effects on HIV‐RT PCR in HIV+ individuals. Third Conference on Retroviruses and Opportunistic infections. Washington, 1996:140.
Holodniy 1999 {published data only}
    1. Holodniy M, Koch J, Mistal M, Schmidt JM, Khandwala A, Pennington JE, et al. A double blind, randomized, placebo‐controlled phase II study to assess the safety and efficacy of orally administered SP‐303 for the symptomatic treatment of diarrhea in patients with AIDS. American Journal of Gastroenterology 1999;94(11):3267‐73. [MEDLINE: ] - PubMed
Paice 2000 {published data only}
    1. Paice JA, Ferrans CE, Lashley FR, Shott S, Vizgirda V, Pitrak D. Topical capsaicin in the management of HIV‐associated peripheral neuropathy. Journal of Pain and Symptom Management 2000;19(1):45‐52. [MEDLINE: ] - PubMed
Sangkitporn 2004 {published data only}
    1. Sangkitporn DR, Luo SD, Klinbuayaem DR, Leenasirimakul DR, Wirayutwatthana DR, Leechanachai DR, et al. Efficacy and safety of Zidovudine and Zalcitabine combined with combination of herbs in the treatment of HIV‐infected Thai patients. Abstract of XV International AIDS Conference. Bankok, Thailand, July, 2004:B10233. - PubMed
Shi 2003 {published data only}
    1. Shi D, Peng ZL. Randomised, double‐blind, placebo‐controlled clinical study on Qiankunning for HIV/AIDS. Study Journal of Traditional Chinese Medicine 2003;21(9):1472‐4.
Weber 1999 {published data only}
    1. Weber R, Christen L, Loy M, Schaller S, Christen S, Joyce CR, et al. Randomized, placebo‐controlled trial of Chinese herb therapy for HIV‐infected individuals. Journal of Acquired Immune Deficiency Syndrome 1999;22(1):56‐64. [MEDLINE: ] - PubMed

References to studies excluded from this review

Calabrese 2000 {published data only}
    1. Calabrese C, Berman SH, Babish JG, Ma X, Shinto L, Dorr M, et al. A phase I trial of Andrographolide in HIV positive patients and normal volunteers. Phytotherapy Research 2000;14:333‐8. - PubMed
Cohen 2000 {published data only}
    1. Cohen MR, Mitchell TF, Bacchetti P, Chil C, Crawford S, Gaeddert A, et al. Use of a Chinese herbal medicine for treatment of HIV‐associated pathogen‐negative diarrhea. Integrative Medicine 2000;2(2):79‐84. - PubMed
Gowdey 1995 {published data only}
    1. Gowdey G, Lee RK, Carpenter WM. Treatment of HIV‐related hairy leukoplakia with podophyllum resin 25% solution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995;79(1):64‐7. - PubMed
Guan 2003 {published data only}
    1. Guan CF, Wang J, Xu SL, Yu ZM, Zhang YX, Li GQ, et al. Clinical and experimental study on treatment of HIV/AIDS patients by Zhongyan No. 2. Chinese Journal of Integrated Traditional and Western Medicine 2003;23(7):494‐7.
Guo 1994 {published data only}
    1. Guo QS. Effect of Garlic in AIDS: treatment report of 98 cases. General Clinical Medicine 1994;10(3):163.
Huang 1998a {published data only}
    1. Huang RZ, Zhang LX, Liu G, Huang WP, Jia XY, Naomi Mpemba. Clinical observation on 16 cases of AIDS complicated with herpas zoster treated with Ji Desheng's snake‐venom remedy. Journal of Traditional Chinese Medicine 1998;39(12):726‐7.
Huang 1998b {published data only}
    1. Huang RZ, Zhang LX, Huang WP, Liu G, Jin LX, Jia XY. Clinical observation on 12 cases of AIDS thrush treated by Gargling with Gemma Agrimoniae powder. Chinese Journal of Information on Traditional Chinese Medicine 1998;5(11):33‐4.
Huang 1998c {published data only}
    1. Huang RZ, Zhang LX, Liu G, Huang WP, Liu H, Jia XY, et al. Clinical observation of 13 cases of AIDS treated by Hongmao Wujia polysaccharide. Chinese Journal of Information on Traditional Chinese Medicine 1998;5(10):32‐3.
Huang 1999 {published data only}
    1. Huang WP, Lu WB, Huang RZ, Zhang WX, Liu G, Jia XY, et al. Clinical observation on 22 cases of HIV infection treated with Ai Tong. Journal of Traditional Chinese Medicine 1999;40(10):606‐8.
Huang 2002 {published data only}
    1. Huang WP, Wang J, Yu ZM, Wen RX, Zhang YX. Ai Tong for treatment of 15 individuals with HIV infeciton or AIDS. Chinese Journal of Information on Traditional Chinese Medicine 2002;9(11):49‐50.
James 2000 {published data only}
    1. James JS. Marijuana safety study completed: weight gain, no safety problems. AIDS Treat News 2000, issue 348:3‐4. - PubMed
Jia 1998 {published data only}
    1. Jia XY, Lu WB, Zhang LX, Huang RZ, Huang WP, Liu G, et al. Observation on the laboratory criteria in 10 cases infected with HIV by using Chinese traditional medicine which can invigorate the circulation of blood and reduce the thrombosis. Chinese Journal of Prevention and Control of STD & AIDS 1998;4(6):273‐4.
Jiang 2003 {published data only}
    1. Jiang WM, Pan JZ, Kang LY, Lu HZ, Wong XH. Evaluation of efficacy of XQ‐9302 a Chinese herb, in the treatment of HIV carriers and AIDS patients. Chinese Journal of AIDS and STD 2003;9(6):341‐2.
Kang 1999a {published data only}
    1. Kang LY, Pan XZ, Pan QC, Li GH, Jin ZC, Xue YL, et al. Preliminary study of Chinese herbs in the treatment of 18 cases of HIV carriers and AIDS patients. Chinese Journal of Infectious Diseases 1999;17(1):44‐6.
Kang 1999b {published data only}
    1. Kang LY, Pan XZ, Yang WX, Pan QC, Weng XH, Yang WQ. Chinese herbal formula XQ‐9302: pilot study of its clinical and in vitro activity against human immunodeficiency virus. Hong Kong Medical Journal 1999;5(2):135‐9. [MEDLINE: ] - PubMed
Kusum 2004 {published data only}
    1. Kusum M, Klinbuayaem V, Bunjob M, Sangkitporn S. Preliminary efficacy and safety of oral suspension SH, combination of five chinese medicinal herbs, in people living with HIV/AIDS ; the phase I/II study. Journal of the Medical Association of Thailand 2004;87(9):1065‐70. [MEDLINE: ] - PubMed
Li 1993 {published data only}
    1. Li GQ, Lu WB, Zhou ZK, Yue YH. Clinical observation of Chinese medicine for treating AIDS patients with respiratory infection. Journal of Traditional Chinese Medicine 1993;34(11):671‐2.
Li 1996 {published data only}
    1. Li G, Yue Y, Lu W, Zhou Z. Clinical investigation of traditional Chinese medicine and pharmacy in treating respiratory tract infections in AIDS. Journal of Traditional Chinese Medicine 1996;16(1):3‐6. [MEDLINE: ] - PubMed
Li 1997 {published data only}
    1. Li JM. Ai moxibustion for treatment of diarrhea in 60 cases of AIDS. Yunnan Journal of Traditional Chinese Medicine and Materia Medica 1997;18(2):29.
Li 1998 {published data only}
    1. Li M, Li YK, Wang K, Wu LM, Feng XZ, Li TF, et al. Extract Spring of Life (ESOL) for treatment of AIDS and its relevant syndrome. Chinese Journal of Prevention and Control of STD & AIDS 1998;Suppl:131‐5.
Lin 2002 {published data only}
    1. Lin XD, Xu LZ, Feng Y, Li J, Pei LJ, Shen TQ, et al. Clinical study on treatment of HIV infected persons based on viral load detection and CD4+ T lymphocyte counting. Chinese Journal of Experimental and Clinical Virology 2002;16(3):211‐4. - PubMed
Liu 1999 {published data only}
    1. Liu G, Lu WB. Sheng Dahuang powder for treating 9 HIV infected cases with herpes zoster infection. Chinese Journal of Integrated Traditional and Western Medicine 1999;19(2):123.
Liu 2000 {published data only}
    1. Liu G, Zhang WX, Huang WP, Jia XY, Huang RZ. Treatment of 38 cases of advanced AIDS patients using 'Jianpi Yishen' recipe. Journal of Traditional Chinese Medicine 2000;41(3):186.
Lu 1993 {published data only}
    1. Lu WB. A report of 60 cases of HIV infection by treatment of herbal medicine 'Ke Ai Ke'. Chinese Journal of Integrated Traditional and Western Medicine 1993;13(6):340‐2. [MEDLINE: ] - PubMed
Lu 1995 {published data only}
    1. Lu W. Prospect for study on treatment of AIDS with traditional Chinese medicine. Journal of Traditional Chinese Medicine 1995;15(1):3‐9. [MEDLINE: ] - PubMed
Lu 1997 {published data only}
    1. Lu WB, Wen RX, Guan CF, Wang YZ, Shao J, Mshiu E, et al. A report on 8 seronegative converted HIV/AIDS with traditional Chinese medicine. Chinese Journal of Integrated Chinese and Western Medicine 1997;17(5):271‐3. - PubMed
Lu 1998 {published data only}
    1. Lu WB, Zhao XM, Guan MK, Gu YH, Huang WP, Mpemba N, et al. Clinical study on 21 Shiji Kangbao for treating 13 cases of HIV infection. China Journal of Basic Medicine in Traditional Chinese Medicine 1998;4(2):50‐1.
Lu 2000 {published data only}
    1. Lu WB, Tang JJ, Huang RZ, Zhao XM, Huang WP, Mu PB, et al. Clinical report of Xinshiji Kangbao for treating 43 AIDS patients. Chinese Journal of Prevention and Control of STD & AIDS 2000;6(3):168‐9.
Su 1990 {published data only}
    1. Su CL. Clinical report of traditional Chinese medicine for treating 30 AIDS patients. Journal of Traditional Chinese Medicine 1990;10(1):27‐30.
Sun 1999 {published data only}
    1. Sun Y, Wu ZP, Ni YP, An KG, Wang SY, Zhang XS. Clinical observation of treating AIDS 31 cases with Aitaiding. Chinese Journal of Ethnomedicine and Ethnopharmacy 1999;5(5):258‐61.
Tani 2002 {published data only}
    1. Tani M, Nagase M, Nishiyama T. The effects of long‐term herbal treatment for pediatric AIDS. The American Journal of Chinese Medicine 2002;30(1):51‐64. - PubMed
Tshibangu 2004 {published data only}
    1. Tshibangu KC, Worku ZB, Jongh MA, Wyk AE, Mokwena SO, Peranovic V. Assessment of effectiveness of traditional herbal medicine in managing HIV/AIDS patients in South Africa. East African Medical Journal 2004;81(10):499‐504. - PubMed
Wang 2000 {published data only}
    1. Wang J, Lu WB, Li GQ, Yu ZM, Pan WX, Lu Y, et al. Clinical study of Jin Sheng Bao capsule for treating 22 cases of HIV infection. Chinese Journal of Basic Medicine of Traditional Chinese Medicine 2000;6(7):33‐5.
Wang 2001 {published data only}
    1. Wang J, Yu Z, Li G, Zhang Y, Guan C, Lu W. Clinical observation on the therapeutic effects of zhongyan‐2 recipe in treating 29 HIV‐infected and AIDS patients. Journal of Traditional Chinese Medicine [English version] 2002;22(2):93‐8. [MEDLINE: ] - PubMed
    1. Wang J, Yu ZM, Li GQ, Zhang YX, Guan CF, Lu WB. Clinical observation on 29 cases of HIV infection and AIDS treated with Zhong Yan No. 2. Journal of Traditional Chinese Medicine 2001;42(7):418‐20.
Wei 2001 {published data only}
    1. Wei JA, Sun LM, Zhang W, Liu G, Tang KT, Su XY, et al. Ai Ling granule for treatment of 40 cases of HIV infected persons in ARC stage. Chinese Journal of TCM Information 2001;8(7):62‐63.
Wu 1992 {published data only}
    1. Wu B. Recent development of studies on traditional Chinese medicine in prophylaxis and treatment of AIDS. Journal of Traditional Chinese Medicine 1992;12(1):10‐20. [MEDLINE: ] - PubMed
Yang 1999 {published data only}
    1. Yang WX, Kang LY, Pan XZ, Pan QC, Yang WQ, Li HG, et al. Preliminary study on therapeutic effect of XQ‐9302 Chinese herbal preparation to AIDS. Shanghai Journal of Traditional Chinese Medicine 1999;33(1):4‐8.
Zhan 2000 {published data only}
    1. Zhan L, Yue ST, Xue YX, Attele AS, Yuan CS. Effects of qian‐kun‐nin, a Chinese herbal medicine formulation, on HIV positive subjects: a pilot study. American Journal of Chinese Medicine 2000;28(3‐4):305‐12. [MEDLINE: ] - PubMed
Zhang 1999 {published data only}
    1. Zhang YL, Zhang TY, Chen JS. Clinical observation of Shuang Huang Lian powder injection for treatment of AIDS. Journal of Shanxi Medical University 1999;30(2):47‐8.
Zhao 1996 {published data only}
    1. Zhao XM, Zhou ZK. Therapeutic study on 55 AIDS patients with herpes zoster. Chinese Journal of Information on Traditional Chinese Medicine 1996;3(8):36‐7.
Zhao 1997 {published data only}
    1. Zhao XM, Lu WB, Guan MH. Experiences in syndrome differentiation treatment of AIDS diarrhea by administration of Ban Xia Xie Xin decoction. Chinese Journal of Information on Traditional Chinese Medicine 1997;4(5):41.
Zheng 1999 {published data only}
    1. Zheng WY, Pi GH, Xu KY, Hu CF, Jiang LS, Hu XF, et al. Therapeutic observation of Chinese medicine 'Zai Sheng Dan' in patients with HIV infection. Chinese Journal of Experimental and Clinical Virology 1999;13(3):291‐4. [MEDLINE: ] - PubMed

References to ongoing studies

Tian 2002 {unpublished data only}
    1. Xinhua News Agency/BBC Monitoring Africa. Testing of herbal HIV/AIDS drug in Zambia. http://www.kaisernetwork.org/daily_reports/rep_index.cfm?DR_ID=12852 10/08/2002.

Additional references

Anonymous 2002
    1. Authors unknown. Evidence shows hepatitis C virus is playing major role in AIDS deaths. AIDS ALERT 2002; Vol. 17, issue 2:13‐6. - PubMed
Bonfanti 1999
    1. Bonfanti P, Capetti A, Rizzardini G. HIV disease treatment in the era of HAART. Biomedicine & Pharmacotherapy 1999;53:93‐105. - PubMed
Burack 1996a
    1. Burack JH, Cohen MR, Hahn JA, Abrams DI. Pilot randomized controlled trial of Chinese herbal treatment for HIV‐associated symptoms. Journal of acquired immune deficiency syndromes and human retrovirology 1996;12(4):386‐93. [MEDLINE: ] - PubMed
Dorrucci 1995
    1. Dorrucci M, Pezzotti P, Phillips AN, Lepri AC, Rezza G. Coinfection of hepatitis C virus with human immunodeficiency virus and progression to AIDS. Italian Seroconversion Study. Journal of Infectious Diseases 1995;172(6):1503‐8. [MEDLINE: ] - PubMed
Durant 1998
    1. Durant J, Chantre Ph, Gonzalez G, Vandermander J, Halfon Ph, Rousse B. Efficacy and safety of Buxus sempervirens preparations (SPV30) in HIV‐infected asymptomatic patients: a multicentre, randomized, double‐blind, placebo controlled trial. Phytomedicine 1998;5(1):1‐10. - PubMed
Eisenberg 1998
    1. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Rompay MV, et al. Trends in alternative medicine use in the United States, 1990‐1997. Results of a follow‐up national survey. Journal of the American Medical Association 1998;280(18):1569‐75. - PubMed
Enwei 2002
    1. Anonymous. Summarized report of clinical study of Chinese medicine Qiankunning in HIV/AIDS [in Chinese]. Webpage: http://www.enwei.com.cn/medicine/products/ 2002.
Ernst 1995
    1. Ernst E. Complementary medicine: common misconceptions. Journal of The Royal Society of Medicine 1995;88(5):244‐7. [MEDLINE: ] - PMC - PubMed
ICH‐GCP 1997
    1. International Conference on Harmonisation Expert Working Group. Code of Federal Regulations & International Conference on Harmonisation Guidelines. Pennsylvania: Parexel/Barnett, 1997.
Ishizaki 1996
    1. Ishizaki T, Sasaki F, Ameshima S, Shiozaki K, Takahashi H, Abe Y, et al. Pneumonitis during interferon and/or herbal drug therapy in patients with chronic active hepatitis. European Respiratory Journal 1996;9(12):2691‐6. - PubMed
Izzo 2001
    1. Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs 2001;61(15):2163‐75. - PubMed
Jadad 1996
    1. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17(1):1‐12. - PubMed
Kjaergard 2001
    1. Kjaergard LL, Villumsen J, Gluud C. Reported methodological quality and discrepancies between large and small randomized trials in meta‐analyses. Annal of Internal Medicine 2001;135(11):982‐9. - PubMed
Liu 2000
    1. Liu G, Zhang WX, Huang WP, Jia XY, Huang RZ. Treatment of 38 cases of advanced AIDS patients using 'Jianpi Yishen' recipe. Journal of Traditional Chinese Medicine 2000;41(3):186.
Lu 1993
    1. Lu WB. A report of 60 cases of HIV infection by treatment of herbal medicine 'Ke Ai Ke'. Chinese Journal of Integrated Traditional and Western Medicine 1993;13(6):340‐2. - PubMed
Martin 2001
    1. Martin‐Carbonero L, Soriano V, Valencia E, Garcia‐Samaniego J, Lopez M, Gonzalez‐Lahoz J. Increasing impact of chronic viral hepatitis on hospital admissions and mortality among HIV‐infected patients. AIDS research and human retroviruses 2001;17(16):1467‐71. [MEDLINE: ] - PubMed
Melchart 1999
    1. Melchart D, Linde K, Weidenhammer W, Hager S, Shaw D, Bayer R. Liver enzyme elevations in patients treated with traditional Chinese medicine. Journal of the American Medical Association 1999;282(1):28‐9. - PubMed
Mills 2005
    1. Mills E, Foster BC, Heeswijk RV, Phillips E, Wilson K, Leonard B, et al. Impact of African herbal medicines on antiretroviral metabolism. AIDS 2005;19(1):95‐7. - PubMed
Moher 1998
    1. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta‐analyses?. Lancet 1998;352:609‐13. - PubMed
Monga 2001
    1. Monga HK, Rodriquez‐Barradas MC, Breaux K, Khattak K, Troisi CL. Hepatitis C virus infection‐related morbidity and mortality among patients with human immunodeficiency virus infection. Clinical Infectious Diseases 2001;33:240‐7. - PubMed
Ozsoy 1999
    1. Ozsoy M, Ernst E. How effective are complementary therapies for HIV and AIDS? ‐ a systematic review. International Journal of STD & AIDS 1999;10(10):629‐35. - PubMed
Schulz 1995
    1. Schulz KF, Chalmers I, Hayes R, Altman D. Empirical evidence of bias. Journal of the American Medical Association 1995;273(5):408‐12. - PubMed
Shafer 1999
    1. Shafer RW, Vuitton DA. Highly active antiretroviral therapy (HAART) for the treatment of infection with human immunodeficiency virus type 1. Biomedicine & Pharmacotherapy 1999;53:73‐86. - PubMed
Sud 2001
    1. Sud A, Singh J, Dhiman RK, Wanchu A, Singh S, Chawla Y. Hepatitis B virus co‐infection in HIV infected patients. Tropical Gastroenterology 2001;22(2):90‐2. [MEDLINE: ] - PubMed
Tirelli 2001
    1. Tirelli U, Bernardi D. Impact of HAART on the clinical management of AIDS‐related cancers. European Journal of Cancer 2001;37:1320‐4. - PubMed
Vella 2000
    1. Vella S, Palmisano L. Antiretroviral therapy: state of the HAART. Antiviral Research 2000;45:1‐7. - PubMed
Vickers 2000
    1. Vickers A. Recent advances: complementary medicine. The British Medical Journal 2000;321:683‐6. - PMC - PubMed
WHO 2002
    1. World Health Organization (WHO). Scaling up antiretroviral therapy in resource‐limited settings. http://www.who.int/HIV_AIDS/first.html 2002.
Wright 2003
    1. Wright CC, Sim J. Intention‐to‐treat approach to data from randomized controlled trials: a sensitivity analysis. Journal of Clinical Epidemiology 2003;56(9):833‐42. - PubMed
Zheng 1999
    1. Zheng WY, Pi GH, Xu KQ, Hu CF, Jiang LS, Hu XF, et al. Therapeutic observation of Chinese medicine 'Zai Sheng Dan' in patients with HIV infection. Chinese Journal of Experimental and Clinical Virology 1999;13(3):291‐4. - PubMed

Substances